Table 2: Lesion signal intensity in T1-weighted images, T2-weighted images, and STIR images, when available in the studies included in this review. Terms used by the authors to describe signal intensity were maintained.
Author and year |
Studied odontogenic lesion |
Uniformity |
Signal intensity |
|||
T1 |
T2 |
T1 |
T2 |
STIR |
||
Unicystica meloblastoma |
||||||
Konouchi, et al. 2006 [8] |
Unicysticameloblastoma (n = 3) |
HO |
HO |
Low SI (hypointense)* |
Markedly high SI (Markedly hyperintese)* |
NR |
Hisatomi, et al. 2011 [9] |
Unicystic ameloblastoma (n = 3)
|
HO
|
HO |
Intermediate SI (n = 2) Slight high (n = 1) (slight hyperintense)* |
Bright high SI (Markedly hyperintese)* |
NR |
Srinivasan, et al. 2012 [14] |
Ameloblastoma (unicystic: 2) |
NR |
NR |
Hypointense |
Hyperintense |
NR |
Han, et al. 2018 [11]
|
Unicystic ameloblastoma (n = 11) |
NR |
NR |
Low to high SI (isointense)* |
High SI (hyperintese)* |
NR |
Vanagundi et al. 2020 [17] |
Unicystic ameloblastoma (n = 5) |
NR |
NR |
Hypointense
|
Hyperintense
|
NR |
Wamasing, et al. 2021 [18]
|
Unicystic ameloblastoma (n = 8)
|
HO (n = 6) HE (n = 2) |
Isointense (n = 6) Hypointense (n = 2) |
Extremely high SI (n = 6) (Markedly hyperintense)* High SI (n = 2 hyperintese)* |
NR |
|
Solid content of ameloblastoma |
||||||
Asaumi, et al. 2005 [7] |
Solid content ameloblastoma (n = 10) |
NR |
NR |
From intermediate to slight high SI (from intermediate to slight hyperintense)* |
From intermediate to high SI (hyperintese)* |
NR |
Hisatomi, et al. 2011 [9] |
Solid ameloblastoma (n = 9) |
Most HO (n = 5) HO (n = 4) |
Most HO (n = 4) HO (n = 5) |
Intermediate SI (n = 5) Most slight high + intermediate SI (n = 1)
Most intermediate, marginal slight high SI (n = 1) (Most isointense and slight hyperintense)*
Most slight low, marginal intermediate SI (n = 1)
Slight high SI (n = 1) (Slight hyperintense; slight low)* |
Most bright high + intermediate SI (n = 3) (Most bight hyperintense and isointense)
Most bright high marginal high SI (n = 1)
Bright high SI (n = 5) (Markedly hyperintense)* |
Same as described for T2 |
Srinivasan, et al. 2012 [14] |
Ameloblastoma (solid content) (n = 8) |
NR |
NR |
Hypointense |
Intermediate to high SI (Intermediate to hyperintense)* |
NR |
Han, et al. 2018 [11]
|
Multicystic ameloblastoma (n = 11) |
NR |
NR |
Low to intermediate SI (hypointense to intermediate)*
|
High SI (hyperintense)* |
NR |
Apajalahti, et al. [23] |
Multicystic ameloblastoma (n = 5) |
HO |
HO or HE |
Intermediate |
High SI (hyperintense)* |
NR |
Cystic content of ameloblastoma |
||||||
Asaumi, et al. 2005 [7] |
Cystic content ameloblastoma (n = 10) |
HO |
HO |
From low SI to slight high (from hypointense to slight hyperintense)* |
High SI (hyperintense)* |
NR |
Minani, et al. 1996 [4] |
Multicystic Ameloblastoma (n = 19) |
HE
|
HE
|
Low SI (hipointese)* |
High SI (hyperintense)* |
NR |
Srinivasan, et al. 2012 [14] |
Ameloblastoma (cystic content (n = 8) |
NR |
NR |
Hypointense |
Hyperintense |
NR |
Han, et al. 2018 [11]
|
Multicystic ameloblastoma (n = 11) |
NR |
NR |
Low to high SI (Isointense)* |
High SI (n = 11) (hyperintese)* |
NR |
Apajalahti, et al. [23] |
Multicystic ameloblastoma (n = 5) |
HO |
HO |
Intermediate (Isointese)* |
Bright SI (hyperintese)* |
NR |
Desmoplastic ameloblastoma |
||||||
Baba, et al. 2020 [13] |
Desmoplasticameloblastoma (n = 6) |
HE |
HE |
Intermediate SI; linear low SI (hypointense)*
SI were observed in 5 cases |
Moderately low SI; with small cystic high SI (Moderately hypointense with hyperintense)* Linear low SI were observed in 5 cases (Linear hypointense)* |
NR |
OKC |
||||||
Hisatomi, et al. 2003 [5] |
OKC (n = 7) |
HO (n = 6) HE (n = 1) |
HE |
Most intermediate to high SI (Most isointense to hyperintense)* |
Most low to high mixed SI (Most hypointese to hyperintense)* |
NR |
Konouchi, et al. 2006 [8] |
OKC (n = 4) |
HO |
HE |
Intermediate-high SI (Isointese to hyperintense)*
|
High markedly SI (Markedly hyperintense)*
|
NR |
Srinivasan, et al. 2012 [14] |
OKC (n = 5)
|
NR |
NR |
Hypointense |
Hyperintense |
NR |
Probst, et al. 2015 [10] |
OKCs (n = 10) |
Most HE |
Notclear |
Tended to be of intermediate SI (isointense)* |
Most high SI (Most hyperintese)* |
Most high SI (Most hyperintese) |
Han, et al. 2018 [11] |
OKC (n = 15) |
NR |
NR |
Low to high SI (Hypointense to hyperintense)* |
High SI (Hyperintense) |
NR |
Ogura, et al. 2019 [12] |
OKC (n = 5) |
HO |
Low SI |
High SI (Hyperintense)* |
High SI (Hyperintense)* |
NR |
Vanagundi, et al. 2020 [17] |
OKC (n = 17)
|
NR |
HE |
Hypointense (52.9%) Hyperintense (47.1%) |
Hypointense (23.5%) Hyperintense (76.5%) |
NR |
Wamasing et al, 2021 [18]
|
OKC (n = 39)
|
HE (n = 37) HO (n = 2) |
Hypointense (n = 3) Isointense (n = 29) Hyperinense (n = 7) |
Low SI (n = 6) (Hipointense)* High SI (n = 30) (Hyperintense)* Extremely high SI (n = 3) (Markedly Hyperintense)* |
NR |
|
Dentigerous Cyst |
||||||
Hisatomi, et al. [5] |
Dentigerous cyst (n = 3) |
HO |
HO |
Slight high SI (Slight Hyperintense)* |
High SI (Hyperintense)* |
NR |
Konouchi, et al. 2006 [8] |
Dentigerous cyst (n = 3) |
HO |
HO |
Low SI (Hypointense) |
Markedly high SI (Markedly Hyperintense)* |
NR |
Srinivasan, et al. 2012 [14] |
Dentigerous cyst (n = 2) |
NR |
NR |
Hypointense |
Hyperintense |
NR |
Han, et al. 2018 [11] |
Dentigerous cyst (n = 3) |
NR |
NR |
low to high SI (Hypointense to hyperintense)*
|
High SI (n = 3) (Hyperintense)* |
NR |
Ogura, et al. 2019 [12] |
Dentigerous cyst (n = 4)
|
HO (n = 2) |
HE (n = 2) |
High SI (Hyperintense)* |
High SI (Hyperintense)*
|
High SI |
Vanagundi, et al. 2020 [17] |
Dentigerous cyst (n = 5) |
NR |
NR |
Hypointense (40%) Isointense to hyperintense (60%) |
Hyperintense
|
NR |
Wamasing, et al. 2021 [18] |
Dentigerous cyst (n = 80)
|
HE (n = 70) HO (n = 3) |
Hyperintense (n = 58) Hypointense (n = 1) Isointense (n = 21) |
High SI (n = 63) (Hyperintense)* Extremely high SI (n = 17) (Markedly hyperintense)* |
NR |
|
|
|
|
|
|
|
|
Glandular odontogenic cyst |
||||||
Hisatomi, et al. 2003 [5] |
Glandular odontogenic cyst (n = 1) |
HO |
HO |
Intermediate SI |
High SI (Hyperintense)* |
NR |
Nasopalatinedusctcyst |
||||||
Hisatomi, et al. 2003 [5] |
Nasopalatine duct cyst (n = 4) |
HO |
HO |
High SI (Hyperintense)*
|
High SI (Hyperintense)*
|
NR |
Ogura, et al. 2019 [12] |
Nasopalatine duct cyst (n = 3)
|
HE |
Low SI (n = 1) High SI (n = 2) |
High SI (Hyperintense)*
|
High SI (Hyperintense)*
|
NR |
Adenomatoid odontogenic tumor |
||||||
Asaumi, et al. 2004 [6] |
Adenomatoidodontogenic tumor (n = 3) |
HO |
HO |
Case 1, 2 and 3: Low SI (Hypointense) |
Case 1: Slight high (Slight Hyperintense)* Case 3: High in cystic portion and intermediate to high in the solid portion (Hyperintense and Isointense)* |
NR |
Odontogenic myxoma |
||||||
Srinivasan, et al. 2012 [14] |
Myxoma (n = 3) |
NR |
NR |
Hypointense |
Hyperintense |
NR |
Kheir, et al. 2013 [15]
|
Odontogenic myxoma (n = 33) |
HE |
HE 90% |
Low to intermediate SI (hypointense to isointense) |
Hyperintense masses |
NR |
Radicular/Periapical cyst |
||||||
Ogura, et al. 2019 [12]
|
Radicular cyst (n = 3)
|
HO |
Low SI (Hypointense) |
High SI (Hyperintense)*
|
High SI |
|
Lizio, et al. 2018 [24] |
Periapical cyst (number of the lesions not specified)
|
NR |
NR |
Low SI (Hypointense) |
Internal content: High SI (Hyperintense)* Fibrous wall of the cyst was evident and hypointense |
NR |
Juerchott, et al. 2018 [16] |
Radicular cyst (5)
|
HO |
HO |
Authors classified the lesions center as “hyperintense” or “hypointense” but not clearly mentioned which lesion has each SI. Also, used the term “inhomogeneous” that was translated to HE in this table. |
NR |
|
Konouchi, et al. 2006 [8] |
Ameloblastoma follicular (n = 1) Ameloblastoma plexiform (n = 3) |
HO |
HE |
Low SI (hypointense)* |
High SI, with multifocal markedly high corresponding to cystic portions (Hyperintense and Markedly hyperintense)*
|
NR |
Abbreviations: HE: Heterogeneous; HO: Homogeneous; SI: Signal Intensity; NR: Not Reported; OKC: Odontogenic Keratocyst *Terms used by the authors to describe SI. Figure 1 and Figure 2 show representative terminology according to signal intensity.